Just when you think a biotech bear market is about to descend, the bulls come rushing in. News of a Greek default depressed markets yesterday and was only compounded by fears […]
PRINCETON, N.J.–(BUSINESS WIRE)–Bristol-Myers Squibb Company (NYSE:BMY) today announced important next steps in the evolution of the company’s R&D organization, including plans to expand its presence within hubs of scientific excellence […]
Immunovaccine and Incyte to Co-Fund Clinical Trial Combining DPX-Survivac and Epacadostat for Patients with Recurrent Disease HALIFAX, NOVA SCOTIA–(Marketwired – June 25, 2015) – Immunovaccine Inc. (“Immunovaccine” or the “Company”) […]
CAMBRIDGE, Mass.–(BUSINESS WIRE)–Eleven Biotherapeutics, Inc. (Nasdaq: EBIO), a clinical-stage biopharmaceutical company discovering and developing protein therapeutics to treat diseases of the eye, today announced that Gregory D. Perry has resigned […]
LOS ANGELES–(BUSINESS WIRE)–NantCell, a subsidiary of NantWorks, LLC, a company focused on the discovery and development of disease treatments through innovative, cell-based therapies at the molecular level, announced today that […]
NEW YORK, NY–(Marketwired – June 19, 2015) – Abeona Therapeutics is focused on developing and delivering gene therapy and plasma-based products for severe and life-threatening rare diseases Established next generation […]
One of the highest-powered events of the BIO 2015 convention in Philadelphia didn’t actually take place in the convention center itself, but up the street from the convention center at […]
R&D efforts on the part of major biopharmaceutical companies for novel drugs to treat depression and other CNS diseases have eroded over the past decade. In fact, a study published […]
Figuring out what disease areas are attracting the most venture funding and deal-related capital in startup and emerging biotech has historically been quite challenging as few if any datasets track […]
Safety platform upgrade delivers more reporting power and greater flexibility and support for worldwide regulatory requirements DIA 2015 — WASHINGTON DC — June 16, 2015 — Oracle Health Sciences […]